Cocrystal Pharma, Inc.
COCPNasdaqCIK 1412486HealthcareFiscal year ends Dec 31
Reports and events: 345 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0908:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-041877 |
| 2026-08-1816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-039023 |
| 2026-08-1716:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-038747 |
| 2026-08-1307:29 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037573 |
| 2026-08-0717:11 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-036650 |
| 2026-08-0307:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035743 |
| 2026-07-1708:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-033662 |
| 2026-06-0907:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-027837 |
| 2026-06-0307:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026965 |
| 2026-05-2716:30 ET | DEF 14A | Proxy statementPeriod 2026-05-27 | 0001493152-26-025428 |
| 2026-05-2608:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-025172 |
| 2026-05-1508:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023377 |
| 2026-04-3016:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-020586 |
| 2026-04-0208:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-014819 |
| 2026-03-3108:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-013838 |
| 2026-03-3108:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013837 |
| 2026-03-1316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-010071 |
| 2026-03-0908:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009309 |
| 2026-02-1908:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-007430 |
| 2026-01-1516:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-002422 |
| 2025-12-1809:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-028296 |
| 2025-12-0116:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025568 |
| 2025-11-1408:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022603 |
| 2025-11-1408:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022581 |
| 2025-10-3016:42 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-020250 |
| 2025-10-3008:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020143 |
| 2025-10-2714:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-019706 |
| 2025-10-0218:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-016751 |
| 2025-09-1916:30 ET | S-1 | Registration statement | 0001493152-25-014266 |
| 2025-09-1516:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-013495 |
| 2025-09-1217:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-027247 |
| 2025-09-1217:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-027246 |
| 2025-08-1408:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023728 |
| 2025-08-1408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023727 |
| 2025-08-0508:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-022153 |
| 2025-07-1016:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-018600 |
| 2025-07-0116:30 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-017370 |
| 2025-06-1816:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-015571 |
| 2025-06-0515:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-013776 |
| 2025-05-2908:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-012791 |
| 2025-05-1508:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010537 |
| 2025-05-1508:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010539 |
| 2025-05-0516:30 ET | DEF 14A | Proxy statementPeriod 2025-05-05 | 0001641172-25-008692 |
| 2025-04-2408:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-005944 |
| 2025-04-2317:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-005876 |
| 2025-04-0816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-003232 |
| 2025-04-0116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002088 |
| 2025-03-3108:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001496 |
| 2025-03-3108:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001494 |
| 2025-01-1308:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-001870 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.